摘要
目的:评价3种用药方案治疗小儿肺炎的经济学效果。方法:采用回顾性研究方法,将120例肺炎患儿按治疗时所选的抗菌药物分为A(头孢甲肟组)、B(头孢唑肟组)、C(头孢美唑组)3组,观察其疗效并进行成本-效果分析。结果:A、B、C 3组的成本分别为481.6、282.8、418.6元;临床有效率分别为90%、85%、77.5%(P>0.05);成本-效果比(C/E)分别为535.11、332.71、540.13;A、C组相对于B组的增量成本-效果比(ΔC/ΔE)分别为3 976.00、1 810.67。结论:B组方案较经济,但C组为最佳方案。
OBJECTIVE：To evaluate the pharmacoeconomic efficacy of three therapeutic schemes in the treatment of pneumonia in children.METHODS：By a retrospective study,according to the treatment of selected antimicrobial agents,a total of 120 children with pneumonia were to Group A（cefmenoxime）,Group B（ceftizoxime） or Group C（cefmetazole）,with therapeutic efficacy observed and cost-effectiveness analysis performed.RESULTS：The costs of the three schemes were 481.6,282.8 and 418.6 yuan,respectively,with clinical effective rates of 90%,85% and 77.5%,respectively（P0.05） and the cost-effectiveness ratios of 535.11,332.71 and 540.13,respectively.The incremental cost-effectiveness ratios of Group A and Group C as against Group B were 3 976.00 and 1 810.67,respectively.CONCLUSION：Scheme B is more economical but scheme C is optimal for treatment of pneumonia in children.
出处
《中国医院用药评价与分析》
2013年第1期7-9,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
